Biofil Chemicals Pharmaceuticals Ltd vs Unjha Formulations Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 34.44 as of 06 May 15:30 . The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 86.4 on March 2021 to 121 on March 2025 . This represents a CAGR of 6.97% over 5 yearsThe P/E Ratio of Unjha Formulations Ltd changed from 37 on March 2021 to 24 on March 2025 . This represents a CAGR of -8.29% over 5 years The Market Cap of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 106.81 crore on March 2021 to ₹ 66.92 crore on March 2025 . This represents a CAGR of -8.93% over 5 yearsThe Market Cap of Unjha Formulations Ltd changed from ₹ 3.81 crore on March 2021 to ₹ 9.78 crore on March 2025 . This represents a CAGR of 20.75% over 5 years The revenue of Biofil Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.93 crore as compare to the Sep '25 revenue of ₹ 13.6 crore. This represent the decline of -93.16% The revenue of Unjha Formulations Ltd for the Dec '25 is ₹ 4.44 crore as compare to the Sep '25 revenue of ₹ 4.35 crore. This represent the growth of 2.07% The ebitda of Biofil Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.17 crore as compare to the Sep '25 ebitda of ₹ 0.18 crore. This represent the decline of -5.56% The ebitda of Unjha Formulations Ltd for the Dec '25 is ₹ 0.28 crore as compare to the Sep '25 ebitda of ₹ 0.85 crore. This represent the decline of -67.06% The net profit of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.08 crore over 7 quarters. This represents a CAGR of -35.00% The net profit of Unjha Formulations Ltd changed from ₹ 0.7 crore to ₹ 0.24 crore over 7 quarters. This represents a CAGR of -45.76% The Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Unjha Formulations Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
Later on, the Company was converted into a Public Limited Company on 7 May '92.
The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

About Unjha Formulations Ltd

Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat.
It was promoted by Shambhubhai A Patel.
The Company is a pioneer in Isabgol (Psyllium) Formulation.
The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
It is one of the largest manufacturers of isabgul products in India.

FAQs for the comparison of Biofil Chemicals & Pharmaceuticals Ltd and Unjha Formulations Ltd

Which company has a larger market capitalization, Biofil Chemicals & Pharmaceuticals Ltd or Unjha Formulations Ltd?

Market cap of Biofil Chemicals & Pharmaceuticals Ltd is 56 Cr while Market cap of Unjha Formulations Ltd is 9 Cr

What are the key factors driving the stock performance of Biofil Chemicals & Pharmaceuticals Ltd and Unjha Formulations Ltd?

The stock performance of Biofil Chemicals & Pharmaceuticals Ltd and Unjha Formulations Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Biofil Chemicals & Pharmaceuticals Ltd and Unjha Formulations Ltd?

As of May 6, 2026, the Biofil Chemicals & Pharmaceuticals Ltd stock price is INR ₹34.44. On the other hand, Unjha Formulations Ltd stock price is INR ₹21.48.

How do dividend payouts of Biofil Chemicals & Pharmaceuticals Ltd and Unjha Formulations Ltd compare?

To compare the dividend payouts of Biofil Chemicals & Pharmaceuticals Ltd and Unjha Formulations Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.